Boris Ševarika Department of Pharmaceutical Sciences Profiles & Affiliations OverviewResearch Publications Publications by Type Projects & Collaborations Academic Activities Academic Self-Administration Continuing Education Junior Development, Doctorate and Advanced Studies Academic Reputation & Networking Teaching Bachelor/Master Projects & Collaborations OverviewResearch Publications Publications by Type Projects & Collaborations Academic Activities Academic Self-Administration Continuing Education Junior Development, Doctorate and Advanced Studies Academic Reputation & Networking Teaching Bachelor/Master Profiles & Affiliations Projects & Collaborations 1 foundShow per page10 10 20 50 NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients. 1 1 OverviewResearch Publications Publications by Type Projects & Collaborations Academic Activities Academic Self-Administration Continuing Education Junior Development, Doctorate and Advanced Studies Academic Reputation & Networking Teaching Bachelor/Master
Projects & Collaborations 1 foundShow per page10 10 20 50 NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients. 1 1
NanoZymeX: Increasing Enzyme Uptake to Normalize the Life Expectancy and Quality of Pompe Patients Research Project | 1 Project MembersNanoZymeX develops lipid nanoparticle–based enzyme replacement therapy for Pompe disease. By improving efficacy and eliminating immunological side effects, we aim to extend the life expectancy and improve the quality of life of Pompe disease patients.
